Biotech

Biotech Investing

Q BioMed Inc. (OTCQB:QBIO) was recently featured on Proactive Investors where company CEO, Denis Corin talked about the company looking to the US Food and Drug Administration to sign off on “a new manufacturing facility to produce Strontium Chloride Sr89 injection.”

Q BioMed Inc. (OTCQB:QBIO) was recently featured on Proactive Investors where company CEO, Denis Corin talked about the company looking to the US Food and Drug Administration to sign off on “a new manufacturing facility to produce Strontium Chloride Sr89 injection.”


To watch the full interview, click here.
Click here to connect with Q BioMed and receive an Investor’s Presentation.

Source: www.proactiveinvestors.com

Featured

MARKETS

Markets
TSX20544.11-51.78
TSXV830.22-16.07
DOW34160.78-7.31
S&P 5004326.51-23.42
NASD13352.78-189.34
ASX6961.60-177.90

COMMODITIES

Commodities
Gold1797.30-24.57
Silver22.76-0.81
Copper4.42-0.10
Palladium2378.34+59.33
Platinum1027.99-6.72
Oil87.29-0.06
Heating Oil2.75+0.06
Natural Gas5.90+1.62

DOWNLOAD FREE REPORTS

×